You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Pineoblastoma in Adults

Chang, Susan M. M.D.; Lillis-Hearne, Patricia K. M.D.; Larson, David A. M.D., Ph.D.; Wara, William M. M.D.; Bollen, Andrew W. M.D.; Prados, Michael D. M.D.

Neurosurgery:
Clinical Study
Abstract

THIS IS THE first report of a series of adults (>16 years of age) with pineoblastomas who had their entire neuraxis staged at the time of diagnosis. Between 1975 and 1992, seven men and four women with histologically proven pineoblastomas were evaluated at the University of California, San Francisco. The median age at diagnosis was 36 years (range, 17–59 yr). All patients presented with symptomatic hydrocephalus. One patient had a complete surgical resection, eight had subtotal resections, and two had biopsies only. One patient refused any treatment or follow-up review and died 6 months after diagnosis. The five patients with positively staged disease had progression either focally or in the spine 8 to 49 months (median, 10 mo) after initial diagnosis and died 1 to 20 months after recurrence; the median overall survival time from the date of surgery was 30 months. In contrast, all five patients with negatively staged disease were alive without disease progression after a median of 26 months of follow-up. Our retrospective review shows that the extent of disease at diagnosis seems to be an important prognostic factor for pineoblastomas, as is true for medulloblastomas and other primitive neuroectodermal tumors. Initial staging should include examination of the cerebrospinal fluid and magnetic resonance imaging of the spine. Although patients with pineoblastomas are often treated with adjuvant systemic chemotherapy after craniospinal irradiation, the benefits of this approach are unclear.

Author Information

Neuro-Oncology Service, Brain Tumor Research Center, Department of Neurological Surgery (SMC, MDP), Department of Radiation Oncology (DAL, WMW), and Department of Pathology (AWB), University of California, School of Medicine, San Francisco, California; and Department of Radiation Oncology (PKL-H), Brook Army Medical Center, Fort Sam Houston, Texas

Reprint requests: Susan M. Chang, M.D., Department of Neurological Surgery, Box 0112, Moffitt Hospital, Room 787, San Francisco, CA 94143.

Received, April 8, 1994. Accepted, March 20, 1995. Data updated, July 25, 1995.

Copyright © by the Congress of Neurological Surgeons